Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Controlled Trial Comparing Efficacy of 8 Weeks Treatment With Clarithromycin and Rifampicin Versus Streptomycin and Rifampicin for Buruli Ulcer (M. Ulcerans Infection)

NCT01659437 is registered in ClinicalTrials.gov with University Medical Center Groningen as lead sponsor.

NCT NCT01659437
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01659437 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Controlled Trial Comparing Efficacy of 8 Weeks Treatment With Clarithromycin and Rifampicin Versus Streptomycin and Rifampicin for Buruli Ulcer (M. Ulcerans Infection)
Lead sponsor
University Medical Center Groningen
Phase
Phase 2/3
Overall status
Completed
Start date
December 31, 2012
Completion date
January 31, 2018
Enrollment
310 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

mycobacterium ulcerans infection